Otogenetics

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

August 6, 2024

Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, Isogai T, Morant R, Castori-Eppenberger S, Chi KN, Wang Y, Helgason CD.(2014) Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 5(3):764-74.

Otogenetics
  • 4553 Winters Chapel Rd., Suite 100 Atlanta, GA 30360
  • +1 (855)-686-4363
Contact Us

Patients

  • GxVISION® Carrier Screening

  • EnVISION Non Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

Physicians

  • GxVISION® Carrier Screening

  • EnVISION Non-Invasive Prenatal® Screening

  • GxVISION® Hereditary Cancer Risk Assessment

  • GxVISION® Congenital Hearing Loss

Education Center

  • Physician Education Resources

  • Patient Education Resources

  • Patient Stories

Research & Partnerships

  • Research and Research Partners

  • GBinsight

Company

  • About Us

  • Contact Us

  • Privacy Policy

© Otogenetics 2025 All Rights Reserved.